Core Viewpoint - The company plans to sell part of its repurchased shares to supplement its working capital, following a structured timeline and regulatory compliance [2][3][4]. Summary by Sections Share Repurchase Overview - The company repurchased 6,926,800 shares from February 2, 2024, to April 30, 2024, representing 3.00% of its total share capital [2][3]. Sale Plan Details - The board approved a plan to sell up to 4,500,000 repurchased shares, which is 1.95% of the total share capital, within six months after 15 trading days from the announcement date [3][4]. - The sale will be conducted through centralized bidding at market prices, with the proceeds aimed at enhancing the company's liquidity [3][4]. Company Structure and Financial Impact - Post-sale, the number of shares in the repurchase account will decrease from 6,926,800 to 2,426,800, changing the holding percentage from 3.00% to 1.05% [7]. - The difference between the sale price and the repurchase price will affect the company's capital reserve but will not impact current profits or future development significantly [7]. Compliance and Regulatory Requirements - The sale must adhere to specific regulations, including price restrictions and volume limits, to ensure compliance with the Shanghai Stock Exchange guidelines [9][10].

Group 1 - The company appointed Ms. Liu Dongmei as the secretary of the board of directors, effective from the date her appointment was approved by the Shanghai Stock Exchange [1][2] - Prior to her official appointment, the duties of the board secretary were temporarily handled by the company's chairman, Mr. Zhang Nengyong [1] - Ms. Liu has completed the necessary training and obtained the required certification to fulfill her role [2] Group 2 - The company repurchased a total of 23,879,700 shares between June 27, 2024, and September 27, 2024, to maintain company value and protect shareholder interests [5] - The repurchased shares are planned to be sold through centralized bidding within twelve months after the completion announcement, and must be sold within three years [5][6] - As of January 31, 2026, the company has not yet sold any of the repurchased shares [7]

Core Viewpoint - Beijing Hotgen Biotech Co., Ltd. is progressing with the sale of repurchased shares to maintain company value and shareholder rights, following regulatory guidelines [2][3]. Group 1: Share Repurchase Overview - The company repurchased a total of 2,893,010 shares from February 8, 2024, to May 7, 2024, representing 3.12% of the current total share capital [2]. - The repurchased shares will be sold through centralized bidding within twelve months after the announcement of the repurchase results [2]. Group 2: Sale Plan Progress - The company plans to sell up to 1,854,158 shares through centralized bidding from January 19, 2026, to July 18, 2026 [3]. - The sale plan was approved during the fourth board meeting on December 23, 2025, in accordance with the repurchase report [3]. Group 3: Sale Implementation Details - The company is required to disclose the sale progress at the beginning of each month, adhering to regulatory requirements [5]. - The sale plan is consistent with previously disclosed plans and commitments, with no major events like stock splits or mergers planned during the sale period [5]. Group 4: Impact of the Sale - The sale aligns with the company's established plan and relevant regulations, with proceeds intended to supplement the company's working capital [6].

Core Viewpoint - The company, Shanghai Yizhong Pharmaceutical Co., Ltd., has initiated a share repurchase program to maintain company value and protect shareholder interests, with plans to sell the repurchased shares within a specified timeframe [2][3]. Group 1: Share Repurchase Details - The company repurchased a total of 1,274,307 shares from August 26, 2024, to December 25, 2024 [2]. - The repurchased shares will be sold through centralized bidding within twelve months after the announcement of the repurchase results, and any unsold shares will be canceled [2]. Group 2: Sale Plan Progress - The company plans to sell up to 1,274,307 repurchased shares, not exceeding 0.62% of the total share capital, within six months from January 22, 2026, to July 21, 2026 [3]. - Proceeds from the sale will be used to supplement the company's working capital to support research and development projects and daily operations [3]. Group 3: Implementation Status - As of January 31, 2026, the company has not yet sold any of the repurchased shares [4]. - The company is required to disclose the progress of the sale plan within the first three trading days of each month [6]. Group 4: Compliance and Regulations - The sale plan is consistent with previously disclosed plans and complies with relevant regulations, including the Shanghai Stock Exchange's guidelines on share repurchase [6]. - The company will adhere to legal requirements during the sale process and fulfill information disclosure obligations [8].

Group 1 - The company has accumulated litigation and arbitration cases amounting to RMB 113.19 million over the past 12 months, which represents 10.52% of the company's audited net assets as of December 31, 2024 [2][3] - There are a total of 60 litigation cases involving the company and its subsidiaries, with approximately RMB 91.17 million in unresolved cases, accounting for 8.47% of the company's audited net assets [3][4] - The company is currently in negotiations or litigation for some cases, leading to uncertainty regarding the impact on current and future profits [5][6] Group 2 - The company repurchased a total of 6,964,139 shares, which is 1.38% of the total share capital, between February 7, 2024, and May 6, 2024 [9] - As of December 4, 2025, the company completed the cancellation of 3,243,680 shares from the repurchase account, reducing the number of shares in the repurchase account to 3,720,459 [10][13] - The company plans to sell up to 3,720,459 repurchased shares through centralized bidding or block trading from October 31, 2025, to February 20, 2026 [11][12]

Core Viewpoint - Kailong High-Tech Co., Ltd. has announced the progress of its share repurchase and sale plan, indicating that as of October 31, 2025, the company has not yet implemented the sale of repurchased shares, which is scheduled to occur between November 17, 2025, and May 16, 2026 [1][3]. Summary by Sections Share Repurchase Overview - The share repurchase plan initiated in 2024 was approved by the board on February 5, 2024, with a budget of between 12 million yuan and 20 million yuan, and a maximum repurchase price of 20.00 yuan per share [2]. - By May 4, 2024, the company had completed the repurchase, utilizing 14.7061 million yuan, which allowed for the repurchase of approximately 73,530 to 147,060 shares based on the maximum price [2]. Sale Plan Progress - The board's decision on October 23, 2025, initiated the sale of 1.2233 million shares, representing 1.06% of the total share capital, with the sale period starting from November 17, 2025, to May 16, 2026 [3]. - As of October 31, 2025, the company had not yet entered the actual sale phase due to the 15 trading day preparation period following the announcement [3]. Future Monitoring - The company is required to disclose the progress of the sale within three trading days of the end of each month, with the next updates expected in November and beyond to assess the sale's pace, pricing, and potential impact on the company's stock price [5].